GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have ...
【导读】子宫内膜癌(EC)是威胁妇女健康的重大疾病,治疗后的复发是一大挑战。虽然胆固醇代谢异常被认为与子宫内膜癌的进展有关,但其潜在机制仍不清楚。在这项研究中,团队发现羊毛甾醇合成酶(LSS)是与乳腺癌相关的胆固醇代谢的关键介质。2025年2月8日, ...
NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Olive oil bioactives, including MUFAs, polyphenols, and triterpenoids, modulate gene expression linked to insulin sensitivity ...
MIAMI - Pasithea Therapeutics Corp. (NASDAQ: KTTA), a micro-cap biotech firm with a market capitalization of $2.63 million focusing on developing treatments for central nervous system disorders and ...
Pasithea Therapeutics (KTTA) announced that the external Safety Review Committee recommended that the Company’s Phase 1 clinical trial of ...
Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, ...
SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with ...
In cancer-associated cachexia, elevated TNF-α and IL-6 exacerbate muscle and fat loss by regulating multiple metabolic signaling pathways, which could be ameliorated by Z526's suppression of NF-κB ...
Macro Risk Advisors (MRA), a leading provider of global market risk analysis and derivatives trade execution for institutional investors, today announced that Adam Knoth has been promoted to Head of ...
BrowserStack, the world's leading software testing platform, today announced that the United States District Court for the Eastern District of Virginia has dismissed all claims brought against it by ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果